ACT EU: Two New Advice Pilots to Improve Clinical Trials in Europe
On 10 June 2024, the Accelerating Clinical Trials in the EU (ACT EU) initiative launched two advice pilots aimed at improving the quality of applications for clinical trials, the foundation for the development of safe and effective medicines in Europe. For more...
Nomination of New Vice Chairperson: Professor Stefan Symeonides
The Cancer Drug Development Forum (CDDF) is delighted to announce that Professor Stefan Symeonides has been nominated as new Deputy Chairperson for a three-year term, succeeding Professor Eva Skovlund. This nomination took effect on 23 May 2024 following the CDDF...
Warm Welcome for PharmaMar to the CDDF Multi-Stakeholder Community
🎉 📣 The Cancer Drug Development Forum (CDDF) is excited to introduce our new Industry member, PharmaMar, who will make collaborative efforts with the CDDF in order to improve the healthcare outcomes of cancer patients. PharmaMar is a unique company as a pioneer of...
[Multi-stakeholder Interview: Get an Inside Look at the CDDF Multi-Stakeholder Discussion on Clinical Research in Central and Eastern Europe]
The Cancer Drug Development Forum (CDDF) is excited to share interview clips featuring a diverse group of stakeholders from our recent Multi-Stakeholder Workshop on Clinical Research in Central and Eastern Europe. Held in Krakow, Poland on 15-16 April 2024, the...
🔔 📣 NEW PUBLICATION: Executive Summary: CDDF Multi-Stakeholder Workshop on Clinical Research in Central and Eastern Europe (15-16 April 2024, PL)
The Cancer Drug Development Forum (CDDF) is delighted to announced that the executive summary of its recent workshop on Clinical Research in Central and Eastern Europe has been published today and is available to all our stakeholders. This workshop took place on 15-...
Warm Welcome for Arvinas to the CDDF Multi-Stakeholder Community
🎉 📣 [Warm Welcome for Arvinas to the CDDF Multi-Stakeholder Community] The Cancer Drug Development Forum (CDDF) is excited to introduce our new Industry member, Arvinas, who will make collaborative efforts with the CDDF to improve cancer drug development. Arvinas is...